Cohera Medical has treated the first patient in a US no-drain clinical study of its TissuGlu Surgical Adhesive, designed for use during large flap surgeries such as abdominoplasty (tummy tuck). The CE-marked internal surgical adhesive ...
Tags: Cohera Medical, no-drain clinical study, TissuGlu Surgical Adhesive
Absorbable surgical adhesives and sealants developer Cohera Medical has obtained $17m in Series D financing through private investors. The capital will be used by the company to expand adoption of its internal surgical adhesive in Germany ...
Tags: adhesives, sealants, surgical adhesive
Cohera Medical has gained investigational device exemption (IDE) from the US Food and Drug Administration (FDA) to commence the first no-drain clinical trial of its internal surgical adhesive. Designed for use during abdominoplasty ...
Tags: Cohera Medical, Cohera, Surgical Adhesive, surgeries
The US Food and Drug Administration (FDA) has granted approval to Cohera Medical's first module of its premarket approval (PMA) application for an internal surgical adhesive. The CE marked internal adhesive, TissuGlu, is designed for ...
Tags: internal surgical adhesive, adhesive, Medical's module
Cohera Medical has initiated a no-drain clinical trial at two Germany-based surgery centers to evaluate TissuGlu surgical adhesive as a treatment for reducing complications in abdominoplasty procedures. CE marked TissuGlu is internal ...